Effects of Behavioural Activation on Emotional Cognition and Mood
1 other identifier
interventional
97
1 country
1
Brief Summary
Behavioural activation (BA) is widely accepted as an efficacious treatment for depression. It has been suggested that several depression treatments work via early changes in emotional processing (e.g. affective bias in the processing of facial expressions) and that these could help predict treatment success, but it has not yet been examined whether the same applies in behavioural interventions. The investigators will examine how BA affects early emotional information processing in participants who are currently experiencing low mood, to see whether this can predict eventual changes in mood and to gain a better understanding of the treatment mechanisms of BA. Participants will be in three groups undergoing either behavioural activation, or activity monitoring alone (active control) for 4 weeks, or they will be on a waiting list (passive control). The investigators will also examine whether other factors, such as anxiety, social support and environmental reward, can predict the success of BA. This could help us understand how BA works and who may be most suitable for this intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Feb 2019
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2019
CompletedFirst Submitted
Initial submission to the registry
April 23, 2019
CompletedFirst Posted
Study publicly available on registry
June 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedMay 10, 2023
May 1, 2023
2.6 years
April 23, 2019
May 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in recognition of positive and negative facial expressions from baseline at week 2 and 4
Hit rate for detecting positive versus negative faces in a facial expression recognition task (FERT)
Will be assessed at week 0, week 3 and week 5 of the intervention
Secondary Outcomes (16)
Median scores on the daily Mood Zoom questionnaire
5 weeks
Motor activity
5 weeks
Change in speed during recognition of positive and negative facial expressions
Will be assessed at week 0, week 3 and week 5 of the intervention
Change in emotional categorisation (ECAT)
Will be assessed at week 0, week 3 and week 5 of the intervention
Change in recall in the Emotional memory task (EREC)
Will be assessed at week 0, week 3 and week 5 of the intervention
- +11 more secondary outcomes
Study Arms (3)
Behavioural activation group
EXPERIMENTALActivity monitoring group
ACTIVE COMPARATORWaiting list control group
NO INTERVENTIONInterventions
4-week programme based on the behavioural activation treatment provided in the NHS IAPT services. The programme includes psychoeducation on the relationship between activity and depression, examining the depressed person's level of activity, helping them identify activities they would like to increase and supporting them in the planning and conduct of those activities.
4-week programme where participants simply monitor their general daily activities in a diary.
Eligibility Criteria
You may qualify if:
- Female or male
- Age: 18 to 65 years
- Competency to give informed consent
- Scores above 14 on BDI-2 (bottom criterion for mild depression)
You may not qualify if:
- Previous participation in a study that used the emotional test battery (ETB)
- Currently undergoing any form of psychotherapy or counselling
- Taking antidepressant medication for less than 3 months, or changing existing psychiatric medication within the past month
- Current or past a diagnosis of psychosis or a bipolar disorder
- Current diagnosis of an eating disorder, a borderline personality disorder, or a substance abuse disorder
- Any other factor that would indicate the participant isn't able to comply with the requirements of the study according to the opinion of the chief investigator (severe insomnia, chronic fatigue syndrome, neurological conditions impairing cognitive function etc.)
- Symptoms of depression are too severe (score 20 and above on the PHQ-9 questionnaire or according to the evaluation of study psychiatrist)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Oxford
Oxford, OX3 7JX, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 23, 2019
First Posted
June 21, 2019
Study Start
February 20, 2019
Primary Completion
September 30, 2021
Study Completion
September 30, 2021
Last Updated
May 10, 2023
Record last verified: 2023-05